IVD CONTRACT MANUFACTURING MARKET REPORT
BY APPLICATION, BY TECHNOLOGY AND BY COUNTRY. TRENDS, KEY MARKET GUIDANCE AND FORECASTS 2024-2029
Eye On IVD Published November 2024 – 50 pages
The demand for in vitro diagnostic (IVD) products that can detect disease, inform therapy decisions, and improve outcomes has led to a corresponding demand for services to make those products efficiently and at scale. Contract manufacturing organizations (CMOs) in the IVD sector play a crucial role in this ecosystem by offering the production capabilities, regulatory expertise, and scalability needed for rapid, reliable test manufacturing. As IVD companies strive to meet growing demands, they often rely on these CMOs to expedite product availability, manage costs, and ensure consistent quality—all essential for launching effective diagnostic solutions in a competitive market.
This report, Contract Manufacturing in IVD, provides a comprehensive look at the marketplace for these services. As contract manufacturers do not generally publish revenues, this report is assembled as the result of interviews with contract organizations manufacturing for OEMs, assessed and synthesized by a knowledgeable IVD expert with contacts in manufacturing. As part of its coverage, the report includes;
- -Executive Summary: Trends, Market Growth and Overall Observations
- -Markets by Product: Immunoassays, Clinical Chemistry, Hematology, Molecular, Microbiology, -Histology, Coagulation, Blood Banking and Other IVD Contract Demand. ($ millions)
- -Forecasts For All Categories To 2029.
- -Markets by Country: United States, Canada, Mexico, UK, Italy, France, Spain, Germany, Other Western Europe, Eastern Europe, China, Japan, India, Latin America, Africa/Mideast
- -COVID-19 Contract Manufacturing Estimated to 2029
- -Testing Category Markets, Including:
- -Instruments
- -Components
- -Supplies
- -Listing of Companies in the Market
CMOs in IVD offer specialized services like assay development, packaging, and kitting, as well as unique insights into regulatory compliance across different global markets. By partnering with a CMO, IVD companies can focus on their core competencies, such as research and development, while leveraging the CMO’s manufacturing infrastructure and expertise. This approach allows companies to scale up production swiftly in response to public health needs, as seen with COVID-19 testing, where CMOs were essential to meet unprecedented demand. In essence, contract manufacturing in IVD is a vital component that helps bring innovative diagnostics to market more efficiently, ultimately supporting better patient outcomes and public health management.
This report provides an unparalleled resource for those conducting business planning in the contract manufacturing industry.
EXECUTIVE SUMMARY
Overall Market for Contract Manufacturing
Contract Manufacturing and Overall IVD Compared
Key Points in the IVD Contract Manufacturing Market
IVD Contract Manufacturing by Type
MARKETS BY PRODUCT
COVID-19 Contract Manufacturing, 2024 to 2029
Molecular
Immunoassays
Immunoassays Contract Manufacturing, 2024 to 2029
Reagents & Test Kits:
Antibodies
Antigens
Other
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Clinical Chemistry Contract Manufacturing, 2024 to 2029
Reagents & Test Kits:
Enzymes:
Glucose
Lipids
Other
Electrolytes
Proteins
Toxicology
Other
Standards & Controls
Instruments & Systems:
Complete Systems:
Components
Supplies & Accessories
Molecular Contract Manufacturing, 2024 to 2029
Reagents & Test Kits:
PCR Reagents
Other Reagents
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Microbiology Contract Manufacturing, 2024 to 2029
Reagents & Test Kits:
Media
ID/STAT
Other Reagents
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Hematology Contract Manufacturing, 2024 to 2029
Reagents & Test Kits:
Diluents & Markers
Other Reagents
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Histology/Cytology, 2024 to 2029
Reagents & Test Kits:
Probes
Antibodies
Other
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Coagulation, 2024 to 2029
Reagents & Test Kits
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Blood Grouping, 2024 to 2029
Reagents & Test Kits
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
Other Technologies, 2024 to 2029
Reagents & Test Kits
Mass Spectrometry
Other
Instruments & Systems:
Complete Systems
Components
Supplies & Accessories
MARKETS BY COUNTRY
North America
United States
Canada
Mexico
Western Europe
Germany
France
United Kingdom
Italy
Spain
Other Western Europe
Asia/Pacific
China
India
Japan
South Korea
Australia
Other Asia/Pacific
Rest of the World
Central & South America
Eastern Europe
Africa/Mideast
TESTING TECHNOLOGY MARKETS
Instruments
Components
Supplies
COMPANIES IN THE MARKET
Bruce Carlson led Kalorama Information healthcare market research from 2008 to 2023. Along with a team of analysts, he conducted and supervised the research for this project. He has been Carlson has a featured speaker at BIO DEVICE market, has conducted numerous webinars in IVD markets. Carlson has worked with contract manufacturing reports since 2014.
